Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 5
2004 1
2005 4
2006 3
2007 3
2008 2
2009 2
2010 6
2011 5
2012 6
2013 5
2014 5
2015 8
2016 13
2017 6
2018 3
2019 5
2020 7
2021 18
2022 19
2023 4
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Results by year

Filters applied: . Clear all
Page 1
Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study.
Allocca M, Catalano G, Savarino EV, Chaparro M, Levartovsky A, Michalopoulos G, Viazis N, Fousekis FS, Psistakis A, Noviello D, Nascimento CND, Caron B, Kitsou V, Bamias G, García MJ, Zacharopoulou E, Foteinogiannopoulou K, D'Amico F, Koutroubakis I, Ellul P, Tzouvala M, Peyrin-Biroulet L, Torres J, Caprioli F, Karmiris K, Theodoropoulou A, Katsanos KH, Christodoulou DK, Mantzaris GJ, Kopylov U, Gisbert JP, Danese S, Magro F, Carla F, Fiorino G. Allocca M, et al. Among authors: bamias g. United European Gastroenterol J. 2024 Feb 28. doi: 10.1002/ueg2.12492. Online ahead of print. United European Gastroenterol J. 2024. PMID: 38419274 Free article.
GSDMB is increased in IBD and regulates epithelial restitution/repair independent of pyroptosis.
Rana N, Privitera G, Kondolf HC, Bulek K, Lechuga S, De Salvo C, Corridoni D, Antanaviciute A, Maywald RL, Hurtado AM, Zhao J, Huang EH, Li X, Chan ER, Simmons A, Bamias G, Abbott DW, Heaney JD, Ivanov AI, Pizarro TT. Rana N, et al. Among authors: bamias g. Cell. 2024 Feb 15;187(4):1011-1015. doi: 10.1016/j.cell.2024.01.010. Cell. 2024. PMID: 38364781 No abstract available.
ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease.
Gordon H, Burisch J, Ellul P, Karmiris K, Katsanos K, Allocca M, Bamias G, Barreiro-de Acosta M, Braithwaite T, Greuter T, Harwood C, Juillerat P, Lobaton T, Müller-Ladner U, Noor N, Pellino G, Savarino E, Schramm C, Soriano A, Michael Stein J, Uzzan M, van Rheenen PF, Vavricka SR, Vecchi M, Zuily S, Kucharzik T. Gordon H, et al. Among authors: bamias g. J Crohns Colitis. 2024 Jan 27;18(1):1-37. doi: 10.1093/ecco-jcc/jjad108. J Crohns Colitis. 2024. PMID: 37351850 No abstract available.
The Underappreciated Role of Secretory IgA in IBD.
Bamias G, Kitsou K, Rivera-Nieves J. Bamias G, et al. Inflamm Bowel Dis. 2023 Aug 1;29(8):1327-1341. doi: 10.1093/ibd/izad024. Inflamm Bowel Dis. 2023. PMID: 36943800 Free PMC article.
Prevalence and predictors of arthralgia after initiation of vedolizumab in patients with inflammatory bowel disease: a retrospective cohort study.
Kokkotis G, Zampeli E, Tzouvala M, Giotis I, Orfanos P, Benetou V, Stoupaki M, Leontidis N, Leonidakis G, Kitsou V, Gaki A, Lagiou P, Michopoulos S, Bamias G. Kokkotis G, et al. Among authors: bamias g. Eur J Gastroenterol Hepatol. 2023 Apr 1;35(4):371-375. doi: 10.1097/MEG.0000000000002527. Epub 2023 Feb 13. Eur J Gastroenterol Hepatol. 2023. PMID: 36827531
Co-expression of fibrotic genes in inflammatory bowel disease; A localized event?
Dovrolis N, Filidou E, Tarapatzi G, Kokkotis G, Spathakis M, Kandilogiannakis L, Drygiannakis I, Valatas V, Arvanitidis K, Karakasiliotis I, Vradelis S, Manolopoulos VG, Paspaliaris V, Bamias G, Kolios G. Dovrolis N, et al. Among authors: bamias g. Front Immunol. 2022 Dec 23;13:1058237. doi: 10.3389/fimmu.2022.1058237. eCollection 2022. Front Immunol. 2022. PMID: 36632136 Free PMC article.
123 results